by Corina Milic | Jul 25, 2018
Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the...
by Corina Milic | Jul 20, 2018
We are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited settings. The new initiative includes an incentive program and...
by Corina Milic | Jul 3, 2018
In Vietnam, a million people are infected with Hepatitis C (HCV). Without treatment, HCV can cause cirrhosis, liver cancer and even death. While no vaccines exist to prevent HCV, the virus is easily treated with directly-acting antivirals (DAAs). In 2017, CHAI worked...
by Corina Milic | Jun 21, 2018
Introducing the second edition of CHAI’s HIV Mid-Year Market Memo, an informational brief that covers the latest trends in the HIV space in low- and middle-income countries (LMICs) since the publication of CHAI’s annual ARV Market Report in September 2017. See the HIV...
by Corina Milic | Jun 19, 2018
Tuberculosis (TB) claims more lives each year than any other infectious disease – a global total of 1.4 million deaths. India accounts for one-third of these, along with 2.7 million new cases each year. The disease afflicts both rural and urban areas, but crowded...
